Literature DB >> 1405960

Posttympanostomy otorrhea: the efficacy of canal preparation.

B A Scott1, C L Strunk.   

Abstract

Otorrhea is the most common posttympanostomy complication. This study is designed to determine the efficacy of canal preparation prior to tympanostomy tube placement. One hundred thirty ears were prospectively randomized into prepared (Betadine and alcohol) and nonprepared (control) groups. Cultures obtained before, during, and after preparation were analyzed to determine the external canal flora and effectiveness of sterilization. Prepared ears and nonprepared control ears were examined for relation to otorrhea. Forty percent of the canals were sterile before preparation, and only 8% harbored suspected pathogenic organisms. Canal preparation successfully sterilized only 33% of the ears that contained bacteria. There was no difference in the otorrhea incidence among treatment groups (9.8%). Based on these bacteriologic and clinical findings, it is concluded that canal preparation with Betadine and alcohol does not reduce posttympanostomy otorrhea.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1405960     DOI: 10.1288/00005537-199210000-00003

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  3 in total

Review 1.  Grommets in otitis media with effusion: the most frequent operation in children. But is it associated with significant complications?

Authors:  Petros V Vlastarakos; Thomas P Nikolopoulos; Stavros Korres; Evangelia Tavoulari; Antonios Tzagaroulakis; Eleftherios Ferekidis
Journal:  Eur J Pediatr       Date:  2007-01-17       Impact factor: 3.183

2.  Mupirocin ointment prevents early post-tympanostomy tube otorrhea: a preliminary study.

Authors:  Kye Hoon Park; Chi-Kyou Lee
Journal:  Korean J Audiol       Date:  2012-12-18

3.  Shepard grommet tympanostomy tube complications in children with chronic otitis media with effusion.

Authors:  Huseyin Yaman; Suleyman Yilmaz; Nihal Alkan; Bugra Subasi; Ender Guclu; Ozcan Ozturk
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-03-05       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.